Erectile Dysfunction and Depression Prevalence Among Male Patients with Type II Diabetes
Khaled Alswat,Ziyad Almorgi,Abdulaziz Aljardahi,Rasheed Alobaylan,Meshal Altowairqi,Majed Almorgi,DaifAllah Almalki,Khalid Alshehri
DOI: https://doi.org/10.2147/jmdh.s455089
2024-05-04
Journal of Multidisciplinary Healthcare
Abstract:Khaled A Alswat, 1 Ziyad Almorgi, 2 Abdulaziz N Aljardahi, 2 Rasheed M Alobaylan, 2 Meshal K Altowairqi, 2 Majed W Almorgi, 2 DaifAllah Mohammed Almalki, 3 Khalid M Alshehri 4 1 Professor of Medicine, Department of Medicine, Taif University, Taif, Saudi Arabia; 2 Medical Intern, Department of Medicine, Taif University School of Medicine, Taif, Saudi Arabia; 3 Consultant of Family Medicine and Diabetes, Diabetes and Endocrinology Center, Prince Mansour Military Hospital, Taif, Saudi Arabia; 4 Consultant of Medicine and Endocrinology, Diabetes and Endocrinology Center, Prince Mansour Military Hospital, Taif, Saudi Arabia Correspondence: Khaled A Alswat, Dean of Graduate Studies, Associate Professor of Medicine, Department of Internal Medicine, Taif University School of Medicine, Airport Road, Taif, Al Huwaya, Saudi Arabia, Tel +127272020, Email Background and Objective: Patients with Type 2 Diabetes (T2D) are at substantial risk for developing erectile dysfunction (ED). The primary goal of this study was to assess the prevalence of ED and depression among T2D patients and the associated risk factors. Methods: A cross-sectional study was conducted for adult T2D patients who had a routine clinic visit between January–August 2023. Structured questionnaires formed with two validated questionnaires – the International Index of Erectile Function short form (IIEF-5) and Patient Health Questionnaire (PHQ-9) – were used to screen for ED and depression, respectively. Results: A total of 478 male patients with T2D with a mean age of 59.2 ± 10.8 years, mostly married, with long standing T2D were included. Hyperlipidemia followed by hypertension were the most reported comorbidities. Of the patients, 61.3% had reported no depression and were less likely to have ED or severe ED ( p < 0.001) and more likely to be physically active and to report no smoking ( p < 0.0001) when compared to those with depression. Fifty-two percent of the patients reported moderate and severe ED and those were older in age ( p = 0.031), had longer duration of T2D diagnosis ( p = 0.005), were more likely to have any comorbidities ( p < 0.05), were less likely to have a university degree and higher income (both p < 0.001), were less likely to be on oral hypoglycemic agents (OHA) ( p < 0.001), had worse glycemic control parameters ( p = 0.463), were more likely to have positive urine microalbuminuria ( p = 0.019), and were less likely to be physically active ( p = 0.048) when compared to patients with no or milder degree of ED. Conclusion: ED is highly prevalent in our study sample, with half of the patients having moderate to severe ED and being more likely to have depression. Older age, long-standing T2D, comorbidities, socioeconomic disadvantage, and sedentary lifestyle were all significantly associated with ED. Keywords: erectile dysfunction, ED, diabetes, T2D, depression, risk factors According to the International Diabetes Federation (IDF), there are 537 million people living with Diabetes Mellitus (DM) worldwide. Furthermore, the total number of people living with DM is projected to rise to 643 million by 2030 and 783 million by 2045. 1 In Saudi Arabia, it is alarming to know that one-fourth of the adult population is affected by type II diabetes (T2D), which is predicted to be doubled by 2030. 2 T2D poses a significant risk for the affected population and leads to serious complications that can affect their lives and these complications are divided into macrovascular and microvascular. The most common macrovascular complication in a recent study is acute myocardial infarction followed by stroke incident and lastly peripheral vascular disease, while nephropathy was the most commonly prevalent microvascular complication followed by retinopathy and neuropathy. 3,4 Erectile dysfunction (ED) affects up to 75% of men worldwide and this condition is characterized by the inability to achieve or keep an erection adequate for sexual intercourse. 5 Furthermore, the prevalence of ED varies as a recent epidemiological study conducted across eight countries showed that up to 45% of men aged 40 years or older reported ED. 6 The prevalence of ED among married men in Saudi Arabia is almost 10%. 7 Many factors can be associated with ED, such as age and medical condition, low education level, low socioeconomic status, and physical activity. 8,9 It is also worth noting that accurately estimating the prevalence and burden of ED is crucial since the condition is often underdiagnosed and undertreat -Abstract Truncated-
health care sciences & services